USE OF SABINE OR TRIVALENT ATTENUATED POLIOVIRUS VACCINE FOR TREATING BELL'S PALSY OR FACIAL PARALYSIS OF VIRAL ETIOLOGY.

摘要

Use of sabine or trivalent attenuated poliovirus vaccine for treating facial paralysis of viral etiology in humans, which is characterized in that it is adapted to be administered in an amount of 0.35 ml. The dose may be orally repeated every 30 days, 3 total applications for obtaining a total remission in a maximum period of time of 3 to 4 weeks, the second and third dose are for reinforcing the treatment.